August corporate presentation
Their August presentation just came out. Says hnscc data comes out October. Everything else is 2nd half 2026 including Casdozo.
Their August presentation just came out. Says hnscc data comes out October. Everything else is 2nd half 2026 including Casdozo.
几年前,我因为持有surf而过度到了chrs,chrs收购surf的时候也发了cvr,看样子又是一样的剧本
Restructured existing loan and pays for now interest only and gets additional $25M later on if revenue is above $35M per quarter in 2028. Value of remaining biosimilar business will be converted into CVRs. Difficult to say if there is true value but I believe it includes a patent licensed to Pfizer. The journey continues and this company continues to execute well.
Quote from Stocktwits:
wCVR perceived as valuable
→ shareholders want guaranteed entitlement
→ shareholders/brokers recall lent CHRS
→ available borrow declines
→ borrow rate rises
→ some shorts voluntarily cover
→ CHRS rises
→ mark-to-market pressure on remaining shorts
→ additional covering“
“No Data” Denny will take us to BK absent a BO in Q4, imho. Tori Tagmo and Casdo are the three stooges of IO, what a joke.